| 13 Tue |
|---|
|
All-day
|
|
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm
9:17 am
Plenary Address: Making sense of pathogen sensors of Innate Immunity: Utility of their ligands as antiviral agens and adjuvants for vaccines.
@ Acharya Hall
Plenary Address: Making sense of pathogen sensors of Innate Immunity: Utility of their ligands as antiviral agens and adjuvants for vaccines.
@ Acharya Hall
Aug 13 @ 9:17 am – 9:55 am
 Suryaprakash Sambhara, DVM, Ph.D Chief, Immunology Section, Influenza Division, CDC, Atlanta, USA Making sense of pathogen sensors of Innate Immunity: Utility of their ligands as antiviral agents and adjuvants for vaccines. Currently used antiviral agents act by inhibiting viral entry,
10:52 am
Invited Talk: Interrogating Signaling Networks at the Single Cell Level in Primary Human Patient Samples
@ Acharya Hall
Invited Talk: Interrogating Signaling Networks at the Single Cell Level in Primary Human Patient Samples
@ Acharya Hall
Aug 13 @ 10:52 am – 11:22 am
 Michelle Hermiston, MD, Ph.D. Assistant Professor, Department of Pediatrics University of California San Francisco, USA Interrogating Signaling Networks at the Single Cell Level In Primary Human Patient Samples Multiparameter phosphoflow cytometry is a highly sensitive proteomic approach that enables monitoring of
5:06 pm
Invited Talk: New paths for treatment of complex diseases: target combinatorial drug therapy
@ Acharya Hall
Invited Talk: New paths for treatment of complex diseases: target combinatorial drug therapy
@ Acharya Hall
Aug 13 @ 5:06 pm – 5:27 pm
 Bodo Eickhoff, Ph.D. Senior Vice-President, Head of Sales and Marketing for Roche Applied Science, Germany New paths for treatment of complex diseases: target combinatorial drug therapy Several types of diseases show a complex pathogenesis and require targeted as well as
|
Subscribe to filtered calendar